Agency Forms Undergoing Paperwork Reduction Act Review, 9346-9348 [E6-2583]
Download as PDF
9346
Federal Register / Vol. 71, No. 36 / Thursday, February 23, 2006 / Notices
Seventeenth Set:
Toxicological profile
NTIS order No.
1. Bromoform/ ..........................................................................................................................
Dibromochloromethane ....................................................................................................
2. Carbon Tetrachloride ...........................................................................................................
3. Hexachlorocyclohexane (gamma) .......................................................................................
Hexachlorocyclohexane (beta) .........................................................................................
Hexachlorocyclohexane (delta) ........................................................................................
Hexachlorocyclohexane (alpha) .......................................................................................
Hexachlorocyclohexane (technical) ..................................................................................
4. Naphthalene ........................................................................................................................
1-Methyl Naphthalene ......................................................................................................
2-Methyl Naphthalene ......................................................................................................
5. Nickel ...................................................................................................................................
6. Tin ........................................................................................................................................
7. Tungsten * ............................................................................................................................
8. Zinc ......................................................................................................................................
PB2006–100001
........................................
PB2006–100002
PB2006–100003
........................................
........................................
........................................
........................................
PB2006–100004
........................................
........................................
PB2006–100005
PB2006–100006
PB2006–100007
PB2006–100008
CAS No.
000075–25–2
000124–48–1
000056–23–5
000058–89–9
000319–85–7
000319–86–8
000319–84–6
000608–73–1
000091–20–3
000090–12–0
000091–57–6
007440–02–0
007440–31–5
007440–33–7
007440–66–6
Note.—* Denotes new profile.
Kevin A. Ryan,
Acting Director, Office of Policy, Planning
and Evaluation, National Center for
Environmental Health/Agency for Toxic
Substances and Disease Registry.
[FR Doc. E6–2577 Filed 2–22–06; 8:45 am]
BILLING CODE 4163–70–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration on Aging
Agency Information Collection
Activities; Extension of Existing
Collection; Comment Request; Title VI
Program Performance Report
Administration on Aging, HHS.
Notice.
AGENCY:
rwilkins on PROD1PC63 with NOTICES
ACTION:
SUMMARY: The Administration on Aging
(AoA) is announcing an opportunity for
public comment on the proposed
collection of certain information by the
agency. Under the Paperwork Reduction
Act of 1995 (the PRA), Federal agencies
are required to publish notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information, and
to allow 60 days for public comment in
response to the notice. This notice
solicits comments on the information
collection requirements relating to the
Title VI Program Performance Report.
DATES: Submit written or electronic
comments on the collection of
information by April 24, 2006.
ADDRESSES: Submit electronic
comments on the collection of
information to:
Yvonne.Jackson@aoa.gov.
Submit written comments on the
collection of information to: Dr. Yvonne
Jackson, Administration on Aging,
Washington, DC 20201.
VerDate Aug<31>2005
16:15 Feb 22, 2006
Jkt 205001
Dr.
Yvonne Jackson, Director; Office of
American Indian, Alaskan Native and
Native Hawaiian Programs, U.S.
Department of Health and Human
Services, Administration on Aging,
Washington, DC 20201; (202) 357–3501.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3520), Federal
agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency request
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, AoA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following collection
of information, AoA invites comments
on: (1) Whether the proposed collection
of information is necessary for the
proper performance of AoA’s functions,
including whether the information will
have practical utility; (2) the accuracy of
AoA’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
when appropriate, and other forms of
information technology.
The Program performance Report
provides a data base for AoA to (1)
monitor program achievement of
performance objectives; (2) establish
program policy and direction, and (3)
prepare responses to Congress, the
Office of Management and Budget, the
General Accounting Office, other
Federal departments, and public and
private agencies as required by the OAA
Title II sections 202(a)19 and 208; and
prepare data for the Federal Interagency
Task Force of Older Indians established
pursuant to section 134(d) of the 1987
Amendments to the OAA.
AoA estimates the burden of this
collection of information as follows: A
total of not more than 729 hours per
year will be required to prepare reports.
Dated: February 17, 2006.
Francis A. Burns,
Deputy Assistant Secretary for Wellness and
Community Based Services.
[FR Doc. E6–2537 Filed 2–22–06; 8:45 am]
BILLING CODE 4154–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–06–06AR]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an e-
E:\FR\FM\23FEN1.SGM
23FEN1
9347
Federal Register / Vol. 71, No. 36 / Thursday, February 23, 2006 / Notices
mail to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
Proposed Project
Home Medkit Evaluation Study
(HoME Study)—New—Coordinating
Office for Terrorism Preparedness and
Emergency Response (COTPER), Centers
for Disease Control and Prevention
(CDC).
The Coordinating Office for Terrorism
Preparedness and Emergency Response
(COTPER), Centers for Disease Control
and Prevention (CDC) proposes to
conduct a one-time-only study called
the Home Medkit Evaluation Study
(HoME Study). This pilot study will be
conducted with selected St. Louis,
Missouri area households who
volunteer. Volunteers would receive in
their homes FDA-approved medicines
that are to be reserved for emergency
use in the event of specific public health
emergency conditions resulting from a
bioterrorist threat.
individual MedKits—cardboard
notebook blister packs with doses for
each household member and patient
instructions, including FDA-approved
crushing instructions for administration
of emergency pediatric doses.
The information collected from this
study will be used to: (1) Assess the
ability of volunteers from select
populations to store and maintain
household MedKits as directed and to
refrain from inappropriate use; (2)
explore attitudes, perceptions, and other
social and psychological factors that
influence participant behavior in
relation to the MedKit; and (3) inform
policy makers and national planners
about the acceptability, safety,
durability, and usefulness of the
household MedKit strategy and
supporting documentation.
There are no previous or existing
studies to provide the specific
information to answer the research
questions proposed in the HoME Study.
There are no costs to the respondents
other than their time. The total
annualized burden hours are 7,253.
The proposed study will provide data
on the extent to which people with
diverse backgrounds are able to follow
instructions concerning appropriate
storage and to reserve the medicine for
emergency use only.
Approximately, 5,000 volunteer
households will be recruited in the St.
Louis, Missouri metropolitan area, and
divided among three cohorts: (a) Public
health emergency responders and their
household members, (b) employees of a
large corporate operation and their
household members, and (c) clients of
publicly-funded primary healthcare
centers, their households, and
surrounding community households.
All will be medically screened for
eligibility to receive a home MedKit
and, if eligible, they will be recruited
and enrolled for study participation
with informed consent. After an initial
in-person baseline interview, they will
receive a MedKit bag with an antibiotic
enclosed. The MedKit bag will consist
of a transparent mylar, tamper-evident
sealed bag with FDA-approved patient
instructions affixed to the outside and
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
Respondents
Form type/respondent category
BEHAVIORAL STUDY:
Recruiting HH Contacts ........................................................................................................
Prescreening & HH Roster ...................................................................................................
Medical Screening:
PH 1st responder HHs .........................................................................................................
Large business partner HHs ................................................................................................
CHC client HHs ....................................................................................................................
Baseline Questionnaire:
PH 1st responder HHs .........................................................................................................
Large business partner HHs ................................................................................................
PHC client HHs ....................................................................................................................
Follow-Up Questionnaire:
PH 1st responder HHs .........................................................................................................
Large business partner HHs ................................................................................................
PHC client HHs ....................................................................................................................
NESTED QUALITATIVE STUDIES: Screening & Recruitment calls:
Study HHs focus groups ......................................................................................................
Non-English speakers focus groups ....................................................................................
In-depth Interview .................................................................................................................
Focus Groups:
PH 1st responders ................................................................................................................
Large business partner employees ......................................................................................
PHC client .............................................................................................................................
Non-English speakers ..........................................................................................................
In-depth Interviews ...............................................................................................................
rwilkins on PROD1PC63 with NOTICES
16:15 Feb 22, 2006
Jkt 205001
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Hours per
response
20,000
4,914
1
1
2/60
5/60
3,800
3,800
3,800
1
1
1
15/60
15/60
15/60
1,227
1,282
1,430
1
1
1
20/60
20/60
20/60
1,227
1,282
1,430
1
1
1
25/60
25/60
25/60
180
40
80
1
1
5/60
15/60
5/60
40
40
40
20
60
1
1
1
1
1
2
2
2
2
1
Notes for Table A.12.1: HH=Household; PHC=Public Health Clinic.
VerDate Aug<31>2005
Frequency
of response
E:\FR\FM\23FEN1.SGM
23FEN1
9348
Federal Register / Vol. 71, No. 36 / Thursday, February 23, 2006 / Notices
Dated: February 15, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–2583 Filed 2–22–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–06–04JZ]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–4794 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
Proposed Project
Preventive Cardiac Health Care
Knowledge, Beliefs, and Behaviors in
Female Carriers of Duchenne/Becker
Muscular Dystrophy—New—National
Center on Birth Defects and
Developmental Disabilities (NCBDDD),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Duchenne/Becker Muscular
Dystrophy (DBMD) is the most common
form of fatal muscular dystrophy in
children. It affects about 1 in 3,500 boys.
Although almost all cases of DBMD are
diagnosed in young males, the genetic
condition that causes DBMD is carried
by females. Today, there are about
40,000 female DBMD carriers in the
United States. Females who carry this
genetic condition generally do not have
symptoms, but some may experience
muscle weakness and fatigue.
Sometimes, they may also develop heart
problems that are characterized by
shortness of breath or an inability to do
moderate exercise. The chance that a
female carrier will develop heart
problems is unknown, but these heart
problems are serious and can be life
threatening. To learn more about the
heart health behaviors of adult female
DBMD carriers, National Center on Birth
Defects and Developmental Disabilities
(NCBDDD), CDC proposes to conduct a
national survey.
This one-time survey will be mailed
to about 7,000 women who are on
mailing lists maintained by DBMD
advocacy groups (Group 1) or are known
by someone on one of the lists (Group
2). The data will be treated in a
confidential manner. Women will be
eligible to complete the survey if they
are at least 19 years old and have given
birth to a son with DBMD or been told
that they definitely or probably carry a
genetic change for DBMD. To comply
with requests from the advocacy
community, the questionnaire will be
provided to friends, relatives, and
acquaintances of women on the above
mailing lists who meet all study
eligibility criteria and personally initiate
contact with the study office about
possible participation (Group 2). All
study materials, including the
questionnaire, will be available in
English and Spanish. Respondents will
also be able to complete an electronic
version of the survey accessed via the
World Wide Web. It will take each
participant about 5 minutes to read the
survey cover letter and about 30
minutes to complete the survey. Group
2 women will also need to complete a
5-minute telephone interview to provide
their mailing address to the study office.
Prior to receiving the survey, Group 1
women will receive an initial approach
letter that will take about 5 minutes to
read. We expect that 80% of the women
who receive a questionnaire will
complete the survey, for a total of 5,600
respondents.
Survey participants will be asked
about social and psychological aspects
of their genetic carrier status, their
sources of social support, their
awareness and knowledge of the link
between carrier status and heart health,
issues about access to specialized
cardiac health care, and sources of
health information that they find
trustworthy, accessible, and
understandable. Postage and a return
envelope will be provided for
participants who choose to complete
and return their survey by mail. There
are no costs to the respondents other
than their time. The total estimated
annualized burden hours are 3,968.
ESTIMATED ANNUALIZED BURDEN TABLE
Number of
respondents
Type of data collection
rwilkins on PROD1PC63 with NOTICES
Initial approach letter (Primary sample only) ...............................................................................
Telephone screen (Secondary sample only) ...............................................................................
Survey cover letter with survey (Primary & Secondary samples) ...............................................
Survey sections 1 through 5 ........................................................................................................
VerDate Aug<31>2005
16:15 Feb 22, 2006
Jkt 205001
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
E:\FR\FM\23FEN1.SGM
6,000
1,000
7,000
5,600
23FEN1
Number of
responses per
respondent
1
1
1
1
Average
burden per
respondent
(in hours)
5/60
5/60
5/60
30/60
Agencies
[Federal Register Volume 71, Number 36 (Thursday, February 23, 2006)]
[Notices]
[Pages 9346-9348]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-2583]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-06-06AR]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-
[[Page 9347]]
mail to omb@cdc.gov. Send written comments to CDC Desk Officer, Office
of Management and Budget, Washington, DC or by fax to (202) 395-6974.
Written comments should be received within 30 days of this notice.
Proposed Project
Home Medkit Evaluation Study (HoME Study)--New--Coordinating Office
for Terrorism Preparedness and Emergency Response (COTPER), Centers for
Disease Control and Prevention (CDC).
The Coordinating Office for Terrorism Preparedness and Emergency
Response (COTPER), Centers for Disease Control and Prevention (CDC)
proposes to conduct a one-time-only study called the Home Medkit
Evaluation Study (HoME Study). This pilot study will be conducted with
selected St. Louis, Missouri area households who volunteer. Volunteers
would receive in their homes FDA-approved medicines that are to be
reserved for emergency use in the event of specific public health
emergency conditions resulting from a bioterrorist threat.
The proposed study will provide data on the extent to which people
with diverse backgrounds are able to follow instructions concerning
appropriate storage and to reserve the medicine for emergency use only.
Approximately, 5,000 volunteer households will be recruited in the
St. Louis, Missouri metropolitan area, and divided among three cohorts:
(a) Public health emergency responders and their household members, (b)
employees of a large corporate operation and their household members,
and (c) clients of publicly-funded primary healthcare centers, their
households, and surrounding community households.
All will be medically screened for eligibility to receive a home
MedKit and, if eligible, they will be recruited and enrolled for study
participation with informed consent. After an initial in-person
baseline interview, they will receive a MedKit bag with an antibiotic
enclosed. The MedKit bag will consist of a transparent mylar, tamper-
evident sealed bag with FDA-approved patient instructions affixed to
the outside and individual MedKits--cardboard notebook blister packs
with doses for each household member and patient instructions,
including FDA-approved crushing instructions for administration of
emergency pediatric doses.
The information collected from this study will be used to: (1)
Assess the ability of volunteers from select populations to store and
maintain household MedKits as directed and to refrain from
inappropriate use; (2) explore attitudes, perceptions, and other social
and psychological factors that influence participant behavior in
relation to the MedKit; and (3) inform policy makers and national
planners about the acceptability, safety, durability, and usefulness of
the household MedKit strategy and supporting documentation.
There are no previous or existing studies to provide the specific
information to answer the research questions proposed in the HoME
Study. There are no costs to the respondents other than their time. The
total annualized burden hours are 7,253.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Frequency of Hours per
Form type/respondent category Respondents response response
----------------------------------------------------------------------------------------------------------------
BEHAVIORAL STUDY:
Recruiting HH Contacts...................................... 20,000 1 2/60
Prescreening & HH Roster.................................... 4,914 1 5/60
Medical Screening:
PH 1st responder HHs........................................ 3,800 1 15/60
Large business partner HHs.................................. 3,800 1 15/60
CHC client HHs.............................................. 3,800 1 15/60
Baseline Questionnaire:
PH 1st responder HHs........................................ 1,227 1 20/60
Large business partner HHs.................................. 1,282 1 20/60
PHC client HHs.............................................. 1,430 1 20/60
Follow-Up Questionnaire:
PH 1st responder HHs........................................ 1,227 1 25/60
Large business partner HHs.................................. 1,282 1 25/60
PHC client HHs.............................................. 1,430 1 25/60
NESTED QUALITATIVE STUDIES: Screening & Recruitment calls:
Study HHs focus groups...................................... 180 1 5/60
Non-English speakers focus groups........................... 40 .............. 15/60
In-depth Interview.......................................... 80 1 5/60
Focus Groups:
PH 1st responders........................................... 40 1 2
Large business partner employees............................ 40 1 2
PHC client.................................................. 40 1 2
Non-English speakers........................................ 20 1 2
In-depth Interviews......................................... 60 1 1
----------------------------------------------------------------------------------------------------------------
Notes for Table A.12.1: HH=Household; PHC=Public Health Clinic.
[[Page 9348]]
Dated: February 15, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E6-2583 Filed 2-22-06; 8:45 am]
BILLING CODE 4163-18-P